Work

A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3550

Authors: P. J. O’Dwyer, P. LoRusso, A. DeMichele, V. Gupta, A. Barbi, H. Dials, I. Chen, R. Courtney, K. Wilner, G. K. Schwartz

Institutions: Memorial Sloan Kettering Cancer Center, Pfizer (United States), The Barbara Ann Karmanos Cancer Institute, University of Pennsylvania

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2268329279

Cites:

Cited by: 20

Related to: 10